Skip to content

Online guided vs. unguided cognitive behavioral therapy for distress in people who lost a loved one during the COVID-19 pandemic: A controlled trial

The effectiveness of an online cognitive behavioral therapy for people who lost loved ones during the COVID-19 pandemic: A controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON24026
Enrollment
102
Registered
2021-05-18
Start date
2021-03-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Persistent Complex Bereavement Disorder, Posttraumatic Stress Disorder, depression.

Interventions

The investigational treatment consists of a guided online grief-specific CBT aimed at people who report clinically relevant levels of PCBD, PTSD and/or depression, at least three months after the loss
Schut & Stroebe, 2005). The guided online CBT consists of eight weekly sessions tailored to this specific population. During treatment, participants will be supported by a trained psychologist through
the circumstances and story of the loss are addressed in detail, and the participant is encouraged to face stimuli that are avoided. Further, a rationale of exposure is provided using examples of avoi
these sessions are aimed

Sponsors

Utrecht University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria for participation in the study are as follows: 1) having lost a loved one (i.e., a family member, spouse or friend), 2) the death occurred at least three months earlier during the COVID-19 pandemic (period March 2020 until present), 3) at least 18 years of age and 4) report clinically relevant symptoms of PCBD, PTSD, and/or depression based on clinical telephone interviews.

Exclusion criteria

Exclusion criteria: Exclusion criteria are the following: 1) no mastery of the Dutch language, 2) no Internet access and/or 3) suffering from a psychotic disorder or suicidality.

Design outcomes

Primary

MeasureTime frame
PCBD symptoms will be assessed with the Traumatic Grief Inventory – Clinician-Administered (Lenferink et al., in prep.).

Secondary

MeasureTime frame
PTSD symptoms will be assessed with the PTSD Checklist for DSM-5 (Blevins, Weathers, Davis, Witte, & Domino, 2015). Depression symptoms will be assessed with the Patient Health Questionnaire (PHQ-9; Kroenke, Spitzer, & Williams, 2001).

Contacts

Public ContactLyanne Reitsma

Utrecht University

l.reitsma@uu.nl06-22299573

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)